The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?-Reference-Cited by-同舟云学术

The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?

Published:2014-04-09 Issue:6 Volume:10 Page:713
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Duits Flora H.¹,Teunissen Charlotte E.²,Bouwman Femke H.¹,Visser Pieter‐Jelle¹³,Mattsson Niklas⁴⁵,Zetterberg Henrik⁴⁶,Blennow Kaj⁴,Hansson Oskar⁷,Minthon Lennart⁷,Andreasen Niels⁸,Marcusson Jan⁹,Wallin Anders⁴,Rikkert Marcel Olde¹⁰,Tsolaki Magda¹¹,Parnetti Lucilla¹²,Herukka Sanna‐Kaisa¹³,Hampel Harald¹⁴,De Leon Mony J.¹⁵,Schröder Johannes¹⁶,Aarsland Dag¹⁷,Blankenstein Marinus A.²,Scheltens Philip¹,Flier Wiesje M.¹¹⁸

Affiliation:

1. Alzheimer Center and Department of Neurology, Neuroscience Campus AmsterdamVU University Medical CenterAmsterdamThe Netherlands

2. Department of Clinical ChemistryVU University Medical CenterAmsterdamThe Netherlands

3. Department of Psychiatry and NeuropsychologyInstitute of Brain and Behaviour, University of MaastrichtMaastrichtThe Netherlands

4. Department of Neurochemistry and Psychiatry, Institute of Neuroscience and PhysiologyThe Sahlgrenska Academy at University of GothenburgMölndalSweden

5. Department of Veterans Affairs Medical CenterCenter for Imaging of Neurodegenerative DiseasesSan FranciscoCAUSA

6. UCL Institute of NeurologyQueen SquareLondonUK

7. Clinical Memory Research Unit, Department of Clinical SciencesLund UniversityLundSweden

8. KI‐Alzheimer Disease Research CentreKarolinska Institute, Karolinska University HospitalStockholmSweden

9. Division of Geriatric MedicineDepartment of Neuroscience and LocomotionLinköping UniversityLinköpingSweden

10. Donders Institute for Brain Cognition and BehaviourRadboud Alzheimer CenterNijmegenThe Netherlands

11. Memory and Dementia Centre, 3rd Department of NeurologyAristotle University of Thessaloniki, “G. Papanicolaou” General HospitalThessalonikiGreece

12. Clinica NeurologicaUniversity of PerugiaPerugiaItaly

13. Department of NeurologyUniversity of Eastern Finland and Kuopio University HospitalKuopioFinland

14. Département de Neurologie & Institut de la Mémoire et de la Maladie d'Alzheimer PavillonUniversité Pierre et Marie Curie, François Lhermitte Hôpital de la SalpêtrièreParisFrance

15. Center for Brain HealthNew York UniversitySchool of MedicineNew YorkNYUSA

16. Sektion GerontopsychiatrieUniversität HeidelbergHeidelbergGermany

17. Centre for Age‐Related MedicineStavanger University HospitalStavangerNorway

18. Department of Epidemiology and BiostatisticsVU University Medical CenterAmsterdamThe Netherlands

Funder

Alzheimer Nederland and Stichting VUMC

Stichting Dioraphte

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2013.12.023

Reference38 articles.

1. Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF

2. Cerebrospinal Fluid Tau and β-Amyloid 42 Proteins Identify Alzheimer Disease in Subjects With Mild Cognitive Impairment

3. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

4. Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults

5. Usability of Cerebrospinal Fluid Biomarkers in a Tertiary Memory Clinic

Cited by 255 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How fiber bundle alterations differ in presumed LATE and amnestic Alzheimer's disease;Alzheimer's & Dementia;2024-08-28

2. Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice;Alzheimer's & Dementia;2024-08-03

3. CSF dynamics of orexin and β-amyloid42 levels in narcolepsy and Alzheimer’s disease patients: a controlled study;Neuroscience Letters;2024-08

4. Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression;Alzheimer's Research & Therapy;2024-07-25

5. Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease;Annals of Neurology;2024-05-23